Anatomic Pathology Market

Anatomic Pathology Market by Products & Services (Instruments [Microtomes & Cryostat, Tissue Processors, Automatic Stainers, and Other Products], Consumables [Reagents & Antibodies, Probes & Kits, and Others], and Services), Applications (Disease Diagnosis, Drug Discovery & Development, and Others), End-users (Hospitals, Research Laboratories, Diagnostic Laboratories, and Others), and Regions (Asia Pacific, North America, Latin America, Europe and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-790
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 186
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global anatomic pathology market size was valued at USD 17.56 billion in 2020 and is projected to expand at a substantial CAGR during the forecast period, 2021 – 2028. The growth of the market is attributed to the rising dependence on biomarkers that are based on pathology procedures and tests to discover tumorigenesis and malignancy. The growth in the use of clinical biomarkers allows pathologists to find out disease pathogenesis at a molecular level and helps for better patient outcomes by clinical decision-making.
 

Anatomic Pathology Market Key Takeaways


The anatomic pathological practices are improved by using advanced equipment such as gross imaging, digital microscopes, and staining systems. Unlike other conventional techniques, these digital imaging devices help to provide better solutions such as specific and accurate result. The use of digital imaging is a key factor expected to fuel the anatomic pathology market. Several companies in the market are constantly engaged in efforts to introduce upgraded and advanced pathology development to offer ease of use and favorable design.

Furthermore, key companies are making agreement and partnership for effective portfolio to avoid challenges which affects disease management. For instance, Sakura Finetek USA, in October 2018, partnered with Henry Ford Health System Pathology and Laboratory Medicine for the advancement of automation level in anatomic pathology laboratories. The integration of automation optimizes anatomical pathology with higher productivity by reducing turnaround time and errors in labs.

Market Trends, Drivers, Restraints, and Opportunities

  • Growing number of pathology training programs being conducted by governments on regular intervals with an aim to spread awareness about technological advancement and legal issues of anatomic pathology. This is expected to boost the market.
  • Rising prevalence and incidences of chronic illness such as cancer, diabetes, and cardiovascular diseases globally are key factors responsible to drive the market growth.
  • Growing number of the world population, rising demand for pathology services, and growing elderly population are some factors driving the market.
  • Lack of high skilled laboratories staffs and technicians handling the processing number of specimens and other diagnostic procedures are expected to restrict the anatomic pathology market growth.
  • Ongoing vast R&D activities to develop innovative technology and new devices for anatomic pathology researches are offering lucrative opportunities for the market growth.

Scope of the Report

The report on the global anatomic pathology market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Anatomic Pathology Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Products & Services (Instruments [Microtomes & Cryostat, Tissue Processors, Automatic Stainers, and Other Products], Consumables [Reagents & Antibodies, Probes & Kits, and Others], and Services), Applications (Disease Diagnosis, Drug Discovery & Development, and Others), End-users (Hospitals, Research Laboratories, Diagnostic Laboratories, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Thermo Fisher Scientific, Inc., Cardinal Health, Inc., F. Hoffmann-La Roche AG, Agilent Technologies, Inc., Sakura Finetek USA, Inc., Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Inc., BioGenex, and Bio SB

 

Anatomic Pathology Market Segment Insights

Consumables segment to hold a large market share
On the basis of products and services, the global anatomic pathology market is divided into instruments, consumables, and services. The products & services segment is further divided into instruments, consumables, and services. The instruments segment is sub-divided into microtomes & cryostat, tissue processors, automatic stainers, and other products. The consumables segment consists of reagents & antibodies, probes & kits, and others.

The consumables segment is projected to hold a large market share during the forecast period owing to accessibility of wide-ranging consumable products for anatomic pathology and ongoing advanced technological development. However, the instruments segment is anticipated to expand at a significant CAGR due to the presence of many market participants available with improved design of instruments. Sakura Finetek launched manual microtome Accu-Cut SRM 300 LT in September 2018. This product was integrated with a new feature called 4-color LED-backlit 3D Precision Chuck. For quick visualization of translucent biopsies, this feature allows to observe paraffin-embedded tissue samples in simplified way.

Drug Discovery & Development segment is expected to grow at a rapid pace
Based on applications, the global anatomic pathology market is divided into disease diagnosis, drug discovery & development, and others. The disease diagnosis segment is projected to constitute a large market share in the coming years owing to wide research on anatomic pathology protocols that gives an opportunity to discover disease etiology and associated outcomes. Hence, in 2019, the segment held a major revenue market share due to extensive applications in disease. The disease diagnosis process at inflammatory and proliferating stromal cells stage aims on detection of tumor, therefore, it reduces costs related to tumor eradication. Additionally, manufacturers are emphasizing on innovation and novel diagnostics techniques, which can fuel the segment growth.

The drug discovery & development segment is projected to expand at a rapid pace over the forecast period owing to wide adoption of the technique for drug discovery and development. During preclinical trials, tissue analysis are extensively adopted by pathologists, which provide plenty of information for pharmaceutical manufacturers. In toxicology assessment, anatomic pathology plays important role in evaluating advance effects of candidate drugs.

Hospital segment to account for a key share
Based on end-users, the global anatomic pathology market is divided into hospitals, research laboratories, diagnostic laboratories, and others. In 2019 the hospitals segment dominated the market in terms of revenue generation due to growing rate of hospitalization of cancer patients along with frequent readmissions in hospitals. The segment is expected to hold a key market share in the coming years owing to high development of hospital based pathological laboratories and availability of well-trained staff and well-developed healthcare infrastructure.

The diagnostic laboratories segment is projected to constitute a large market share in the coming years owing to wide development in advanced testing and equipment. Moreover, the rapid establishment of several research organizations based on diagnostic laboratories and growing number of clinical trials through different ongoing projects are expected to boost the segment growth. To achieve high degree of patient satisfaction, research laboratories are providing complete information about functioning of diseased tissues.
 

Anatomic Pathology Market By End Users


North America to constitute a considerable share
On the basis of regions, the global anatomic pathology market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a large market share in 2019 and is expected to constitute a considerable share in the coming years due to governments’ initiatives to encourage extensive research in the field. The presence of major players and increasing implementation of tissue procedures related to diagnosis in disease screening are key drivers for the regional market growth. Moreover, availability of favorable reimbursement policies especially in the US plays a crucial role to help the regional market growth. On the other hand, the market in Asia Pacific is projected to exhibit a high CAGR during the forecast period due to strengthening demand for franchising pathology laboratories, advanced imaging modalities and rising in facilities of better patient care in the region.
 

Anatomic Pathology Market By Regions

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Anatomic Pathology Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Anatomic Pathology Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Anatomic Pathology Market - Supply Chain
  4.5. Global Anatomic Pathology Market Forecast
     4.5.1. Anatomic Pathology Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Anatomic Pathology Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Anatomic Pathology Market Absolute $ Opportunity
5. Global Anatomic Pathology Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Anatomic Pathology Market Size and Volume Forecast by Applications
     5.3.1. Disease Diagnosis
     5.3.2. Drug Discovery & Development
     5.3.3. Others
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Anatomic Pathology Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Anatomic Pathology Market Size and Volume Forecast by End Users
     6.3.1. Hospitals
     6.3.2. Research Laboratories
     6.3.3. Diagnostic Laboratories
     6.3.4. Others
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Anatomic Pathology Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Anatomic Pathology Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Anatomic Pathology Demand Share Forecast, 2019-2026
8. North America Anatomic Pathology Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Anatomic Pathology Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Anatomic Pathology Market Size and Volume Forecast by Applications
     8.4.1. Disease Diagnosis
     8.4.2. Drug Discovery & Development
     8.4.3. Others
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. North America Anatomic Pathology Market Size and Volume Forecast by End Users
     8.7.1. Hospitals
     8.7.2. Research Laboratories
     8.7.3. Diagnostic Laboratories
     8.7.4. Others
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Anatomic Pathology Demand Share Forecast, 2019-2026
9. Latin America Anatomic Pathology Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Anatomic Pathology Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Anatomic Pathology Market Size and Volume Forecast by Applications
     9.4.1. Disease Diagnosis
     9.4.2. Drug Discovery & Development
     9.4.3. Others
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Latin America Anatomic Pathology Market Size and Volume Forecast by End Users
     9.7.1. Hospitals
     9.7.2. Research Laboratories
     9.7.3. Diagnostic Laboratories
     9.7.4. Others
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Anatomic Pathology Demand Share Forecast, 2019-2026
10. Europe Anatomic Pathology Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Anatomic Pathology Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Anatomic Pathology Market Size and Volume Forecast by Applications
     10.4.1. Disease Diagnosis
     10.4.2. Drug Discovery & Development
     10.4.3. Others
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Europe Anatomic Pathology Market Size and Volume Forecast by End Users
     10.7.1. Hospitals
     10.7.2. Research Laboratories
     10.7.3. Diagnostic Laboratories
     10.7.4. Others
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Anatomic Pathology Demand Share Forecast, 2019-2026
11. Asia Pacific Anatomic Pathology Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Anatomic Pathology Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Anatomic Pathology Market Size and Volume Forecast by Applications
     11.4.1. Disease Diagnosis
     11.4.2. Drug Discovery & Development
     11.4.3. Others
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Asia Pacific Anatomic Pathology Market Size and Volume Forecast by End Users
     11.7.1. Hospitals
     11.7.2. Research Laboratories
     11.7.3. Diagnostic Laboratories
     11.7.4. Others
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Anatomic Pathology Demand Share Forecast, 2019-2026
12. Middle East & Africa Anatomic Pathology Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Anatomic Pathology Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Anatomic Pathology Market Size and Volume Forecast by Applications
     12.4.1. Disease Diagnosis
     12.4.2. Drug Discovery & Development
     12.4.3. Others
  12.5. Basis Point Share (BPS) Analysis by Applications
  12.6. Y-o-Y Growth Projections by Applications
  12.7. Middle East & Africa Anatomic Pathology Market Size and Volume Forecast by End Users
     12.7.1. Hospitals
     12.7.2. Research Laboratories
     12.7.3. Diagnostic Laboratories
     12.7.4. Others
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Anatomic Pathology Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Anatomic Pathology Market: Market Share Analysis
  13.2. Anatomic Pathology Distributors and Customers
  13.3. Anatomic Pathology Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Thermo Fisher Scientific, Inc.
     13.4.2. Cardinal Health, Inc.
     13.4.3. F. Hoffmann-La Roche AG
     13.4.4. Agilent Technologies, Inc.
     13.4.5. Sakura Finetek USA, Inc.
     13.4.6. Quest Diagnostics Incorporated
     13.4.7. Laboratory Corporation of America Holdings
     13.4.8. NeoGenomics Laboratories, Inc.
     13.4.9. BioGenex

Segments Covered in the Report
The global anatomic pathology market has been segmented on the basis of

Products and Services

  • Instruments
    • Microtomes & Cryostat
    • Tissue Processors
    • Automatic Stainers
    • Other Products
  • Consumables
    • Reagents & Antibodies
    • Probes & Kits
    • Others
  • Services

Applications

  • Disease Diagnosis
  • Drug Discovery & Development
  • Others

End-users

  • Hospitals
  • Research Laboratories
  • Diagnostic Laboratories
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Thermo Fisher Scientific, Inc.
  • Cardinal Health, Inc.
  • F. Hoffmann-La Roche AG
  • Agilent Technologies, Inc.
  • Sakura Finetek USA, Inc.
  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings
  • NeoGenomics Laboratories, Inc.
  • BioGenex
  • Bio SB.A

 

Key companies competing in anatomic pathology market are Thermo Fisher Scientific, Inc., Cardinal Health, Inc., F. Hoffmann-La Roche AG, Agilent Technologies, Inc., Sakura Finetek USA, Inc., Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Inc., BioGenex, and Bio SB.

These players were implementing many different strategies to enhance their share in market during the forecast period. Some of the strategies are business expansion, collaborative development and product developments. For instance, for in situ hybridization Agilent Technologies launched a range of probes in June 2018, such as CCND1, BCL6, BCL2, IGH/BCL2, IGH, MALT1, IGH/CCND1, and IGH/MYC.
 

Anatomic Pathology Market By key Players

Buy Report